CHIEF EXECUTIVE OFFICER
Sun, Feb 15, 2026
Feb 15
exercised or converted securities in DAWN
11,688 shares @ $0.00
Increased holdings by +6.40%
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology